GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Mvc Capital (MVC) [hlAlert]

Rating:
Buy MVC
down 23.77 %

Mvc Capital (MVC) rated Buy with price target $15.50 by Maxim Group

Posted on: Wednesday,  Oct 8, 2014  8:25 AM ET by Maxim Group

Maxim Group rated Buy Mvc Capital (NYSE: MVC) on 10/08/2014. Previously Maxim Group rated Buy Mvc Capital (NYSE: MVC) on 08/29/2013.,
when the stock price was $12.45. Since then, Mvc Capital has lost 23.78% as of 09/03/2015's recent price of $9.49.
If you would have followed the previous Maxim Group's recommendation on MVC, you would have lost 23.77% of your investment in 735 days.

MVC Capital, Inc. (MVC Capital) is a non-diversified, closed-end management investment company. MVC Capital provides equity and debt investment capital to fund growth, acquisitions and recapitalizations of small and middle-market companies in a variety of industries primarily located in the United States. Its portfolio company investments consists of common and preferred stock, other forms of equity interests and warrants or rights to acquire equity interests, senior and subordinated loans and convertible securities. Its portfolio has investments in a variety of industries, including medical devices, food and food service, industrial manufacturing, financial services, consumer products, energy and information technology in areas, including the United States, Europe and Asia. In February 2008, GenTek Inc.sold its indirect wholly owned subsidiary, Reheis, Inc. and its Anti-Perspirant Actives business to Summit Research Labs, Inc., a portfolio company of MVC Capital, Inc.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/8/2014 8:25 AM Buy
None
10.90 15.50
as of 10/17/2014
1 Week up  2.02 %
1 Month down  -4.07 %
3 Months down  -12.97 %
1 YTD down  -18.00 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/11/2013 8:25 AM Buy
None
12.75 17.50
8/29/2013 8:25 AM Buy
None
12.45 16.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy